RAPAMYCIN BUT NOT FK506 INHIBITS THE PROLIFERATION OF MONONUCLEAR PHAGOCYTES INDUCED BY COLONY-STIMULATING FACTORS

This publication has 36 references indexed in Scilit:

• The mechanism of action of cyclosporin A and FK506
  Published by Elsevier ,2003
• Signalling through CSF receptors
  Immunology Today, 1991
• Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes
  Cell, 1991
• Two distinct signal transmission pathways in T lymphocytes are inhibited by complexes formed between an immunophilin and either FK506 or rapamycin.
  Proceedings of the National Academy of Sciences, 1990
• Suppression of B cell activation by cyclosporin A, FK506 and rapamycin
  European Journal of Immunology, 1990
• A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilin
  Nature, 1989
• EFFECTS OF COMBINATION TREATMENT WITH FK506 AND CYCLOSPORINE ON SURVIVAL TIME AND VASCULAR CHANGES IN RENAL-ALLOGRAFT-RECIPIENT DOGS
  Transplantation, 1989
• Immunosuppressive effect of FK506 on collagen-induced arthritis in rats
  Clinical Immunology and Immunopathology, 1988
• Effects of serum fractions on the growth of mononuclear phagocytes
  Journal of Cellular Physiology, 1982
• Rapamycin (AY-22,989), a new antifungal antibiotic. I. Taxonomy of the producing streptomycete and isolation of the active principle.
  The Journal of Antibiotics, 1975